查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1751217

CRO 医药分析测试服务市场规模、份额、趋势分析报告：按服务、最终用途、地区、细分市场预测，2025-2030 年

Pharmaceutical Analytical Testing Services In CRO Market Size, Share & Trends Analysis Report By Service (Bioanalytical Testing, Method Development & Validation), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

市场规模与趋势：

预计 2024 年 CRO 药物分析测试服务的全球市场规模将达到 75.2 亿美元，2025 年至 2030 年的复合年增长率将达到 8.61%。

这一增长背后的关键因素是慢性病患病率的不断上升、对外包分析测试服务的需求、对药品研发的投资以及全球向具有成本效益的药物开发流程的转变。

製药公司也越来越多地将业务外包给合约研究组织 (CRO)，以利用专业知识、最大限度地减少基础设施的资本投入，并简化医药品认证过程和监管要求的时间。这些测试在整个研发过程中都至关重要，从原料分析和分析方法验证到稳定性测试和杂质分析。

预计这将推动 CRO 对药物分析测试服务的需求，以开发个人化和精准药物，因为 CRO 提供先进的分析技术，如质谱、NGS、拉曼光谱和自动化/AI，以实现快速准确的测试。

此外，生技药品、生物相似药和先进疗法研发管线的增多，以及为提高药品安全性、有效性和一致性而加强的品管等因素，也促进了市场的成长。此外，合约研究组织（CRO）越来越多地采用自动化、人工智慧和数数位资料管理系统（例如实验室资讯管理系统 (LIMS)），预计将使分析测试流程更加高效可靠。这促使製药公司扩大与CRO的合作，制定成本节约策略并建立策略联盟，从而推动创新、降低风险并缩短上市时间。

此外，全球严格的法律规范也是CRO药物分析测试服务市场的主要驱动力。美国FDA、EMA、PMDA和WHO等监管机构要求进行全面的分析验证、分析方法开发和稳定性测试，以提高药物的安全性、有效性和品质。这些法规变得越来越严格，要求进行详细的特性分析和杂质分析，特别是对于复杂的生技药品、生物相似药和先进的治疗药物。 ICH指南（Q2、Q3、Q6）和GMP/GLP标准的实施加剧了对合规分析方法的需求。频繁的审核和监管检查进一步影响了製药公司聘请具有全球监管知识、检验的基础设施和品管系统的专业CRO，从而能够降低风险、加快核准并保持跨地区的市场进入。

此外，品质源自于设计 (QbD) 原则的采用，强调产品开发的系统化方法，凸显了早期分析表征的重要性。在 QbD 框架下，製药公司必须定义关键品质属性 (CQA)，以确保原料和生产流程的变更不会影响产品效能。美国食品药物管理局 (FDA) 的流程分析技术 (PAT)倡议正在推动对生产参数的即时监控，以保持产品的一致性。这项监管倡议，加上向更复杂配方的转变，正在扩大合约研究组织 (CRO) 在药物分析测试中的作用。预计这些因素将在不久的将来提振整体市场需求。

目录

第一章调查方法与范围

第二章执行摘要

第三章 CRO 製药分析测试服务市场：变数、趋势和范围

  • 市场展望
    • 母市场展望
    • 相关/支持市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 定价模式分析
  • 技术格局
  • 市场分析工具
    • 波特五力分析
    • PESTEL 与 SWOT 分析
    • COVID-19影响分析

第四章 CRO 製药分析测试服务市场：按服务分類的估计和趋势分析

  • CRO 製药分析测试服务市场（按服务）：细分仪表板
  • CRO 製药分析测试服务市场（按服务）：变异分析
  • 按服务分类，2018-2030 年
  • 生物分析测试
    • 临床
    • 非临床
  • 方法开发和检验
    • 可萃取和可浸出
    • 杂质法
    • 技术咨询
    • 其他的
  • 稳定性测试
    • 药物成分
    • 稳定性指标检验
    • 加速稳定性测试
    • 光稳定性测试
    • 其他的
  • 其他的

第五章 CRO 製药分析测试服务市场：按最终用途的估计和趋势分析

  • CRO 医药分析测试服务市场（按最终用途）：细分仪表板
  • CRO 製药分析测试服务市场（依最终用途）：变异分析
  • 依最终用途，2018-2030 年
  • 製药公司
  • 生物製药公司
  • 其他的

第六章：CRO 製药分析测试服务市场：按地区估计和趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
    • 波兰
    • 瑞士
    • 奥地利
    • 捷克共和国
    • 克罗埃西亚
    • 斯洛维尼亚
    • 希腊
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 市场参与企业分类
  • 2024 年公司市场占有率/估值分析
  • 公司简介
    • SGS Societe Generale de Surveillance SA
    • Worldwide Clinical Trials
    • Sofpromed
    • ClinChoice
    • Evotec
    • Eurofins Scientific
    • KYMOS Group
    • ViviaBiotech SL
    • GalChimia
    • TCI Laboratories
    • Cotecna（NEOTRON SpA,）
    • Tentamus
    • Enzymlogic
    • Pharmbiotest
    • UNIFARM-Research Centre
    • ANAPHARM EUROPE, SLU
Product Code: GVR-4-68040-576-3

Market Size & Trends:

The global pharmaceutical analytical testing services in CRO market size was estimated at USD 7.52 billion in 2024 and is projected to grow at a CAGR of 8.61% from 2025 to 2030. This growth is primarily attributed to factors such as the growing prevalence of chronic diseases, demand for outsourcing analytical testing services, investments in pharmaceutical R&D, and a shift toward cost-efficient drug development processes across the globe.

In addition, pharmaceuticals are increasingly outsourced to CROs to utilize specialized expertise, minimize their capital investment in the infrastructure, and streamline the timelines for the drug approval process and regulatory requirements. These tests are essential throughout development, from raw materials analysis and method validation to stability studies and impurity profiling.

As CROs offer advanced analytical technologies such as mass spectrometry, NGS, Raman spectroscopy, and automation/AI for rapid and accurate testing are expected to enhance the demand for pharmaceutical analytical testing services in CROs for developing personalized and precision medicine.

Moreover, factors such as an increasing pipeline of biologics, biosimilars, advanced therapies, and rising stringent quality control to enhance pharmaceutical products' safety, efficacy, and consistency are contributing to market growth. Besides, the expanding adoption of automation, artificial intelligence, and digital data management systems like Laboratory Information Management Systems (LIMS) in CROs is anticipated to boost the efficiency and reliability of analytical testing processes. This led pharmaceutical companies to expand their partnerships with CROs for cost-saving strategies and strategic collaborations that boost innovation, reduce risk, and improve time-to-market.

Furthermore, stringent regulatory frameworks worldwide are another major driver for the pharmaceutical analytical testing services in CRO market. Regulatory authorities such as the U.S. FDA, EMA, PMDA, and WHO require comprehensive analytical validation, method development, and stability testing to enhance drug safety, efficacy, and quality. These regulations are becoming increasingly stringent, particularly for complex biologics, biosimilars, and advanced therapies, mandating in-depth characterization and impurity profiling. The implementation of ICH guidelines (Q2, Q3, Q6) and GMP/GLP standards has intensified the demand for compliant analytical methodologies. Frequent audits and regulatory inspections further influence pharmaceutical companies to engage with specialized CROs possessing global regulatory knowledge, validated infrastructure, and quality management systems, allowing risk mitigation, faster approvals, and sustained market access across geographies.

Further, the adoption of Quality by Design (QbD) principles, which emphasize a systematic approach to product development, highlights the importance of early-stage analytical characterization. Under the QbD framework, pharmaceutical companies must define Critical Quality Attributes (CQAs) and ensure that variations in raw materials or manufacturing processes do not compromise product performance. The FDA's Process Analytical Technology (PAT) initiative promotes real-time monitoring of manufacturing parameters to maintain product consistency. This regulatory push, combined with the industry's transition toward more sophisticated drug formulations, is expanding the role of CROs in pharmaceutical analytical testing. Such aforementioned factors are expected to drive the overall market demand in the near future.

Global Pharmaceutical Analytical Testing Services In CRO Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pharmaceutical analytical testing services in CRO market report based on service, end use and region.

  • Service Outlook (Revenue, USD Million, 2018 - 2030)
  • Bioanalytical Testing
    • Clinical
    • Non-Clinical
  • Method Development & Validation
    • Extractable & Leachable
    • Impurity Method
    • Technical Consulting
    • Others
  • Stability Testing
    • Drug Substance
    • Stability Indicating Method Validation
    • Accelerated Stability Testing
    • Photostability Testing
    • Others
  • Others
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Pharmaceutical Companies
  • Biopharmaceutical Companies
  • Others
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
    • Poland
    • Switzerland
    • Austria
    • Czech Republic
    • Croatia
    • Slovenia
    • Greece
  • Asia Pacific
    • Japan
    • China
    • India
    • Thailand
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Argentina
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Parent Market Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Pharmaceutical Analytical Testing Services in CRO Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Pricing Model Analysis
  • 3.4. Technology Landscape
  • 3.5. Market Analysis Tools
    • 3.5.1. Porter's Five Force Analysis
    • 3.5.2. PESTEL by SWOT Analysis
    • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Pharmaceutical Analytical Testing Services in CRO Market: Service Estimates & Trend Analysis

  • 4.1. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Segment Dashboard
  • 4.2. Pharmaceutical Analytical Testing Services in CRO Market, By Service: Movement Analysis
  • 4.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By Service, 2018 - 2030 (USD Million)
  • 4.4. Bioanalytical Testing
    • 4.4.1. Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Clinical
      • 4.4.2.1. Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Non-Clinical
      • 4.4.3.1. Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Method Development & Validation
    • 4.5.1. Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Extractable & Leachable
      • 4.5.2.1. Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Impurity Method
      • 4.5.3.1. Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Technical Consulting
      • 4.5.4.1. Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Stability Testing
    • 4.6.1. Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Drug Substance
      • 4.6.2.1. Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Stability Indicating Method Validation
      • 4.6.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Accelerated Stability Testing
      • 4.6.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Photostability Testing
      • 4.6.5.1. Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Analytical Testing Services in CRO Market: End Use Estimates & Trend Analysis

  • 5.1. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Segment Dashboard
  • 5.2. Pharmaceutical Analytical Testing Services in CRO Market, By End Use: Movement Analysis
  • 5.3. Pharmaceutical Analytical Testing Services in CRO Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million)
  • 5.4. Pharmaceutical Companies
    • 5.4.1. Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Biopharmaceutical Companies
    • 5.5.1. Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Analytical Testing Services in CRO Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Dashboard
  • 6.2. Regional Market Share Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. North America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.S
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. U.S. Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Canada Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Mexico Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. UK Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Germany Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. France Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Italy Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Spain Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Sweden Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Regulatory Framework
      • 6.4.8.4. Denmark Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Regulatory Framework
      • 6.4.9.4. Norway Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.10. Poland
      • 6.4.10.1. Key Country Dynamics
      • 6.4.10.2. Competitive Scenario
      • 6.4.10.3. Regulatory Framework
      • 6.4.10.4. Poland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.11. Switzerland
      • 6.4.11.1. Key Country Dynamics
      • 6.4.11.2. Competitive Scenario
      • 6.4.11.3. Regulatory Framework
      • 6.4.11.4. Switzerland Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.12. Austria
      • 6.4.12.1. Key Country Dynamics
      • 6.4.12.2. Competitive Scenario
      • 6.4.12.3. Regulatory Framework
      • 6.4.12.4. Austria Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.13. Czech Republic
      • 6.4.13.1. Key Country Dynamics
      • 6.4.13.2. Competitive Scenario
      • 6.4.13.3. Regulatory Framework
      • 6.4.13.4. Czech Republic Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.14. Croatia
      • 6.4.14.1. Key Country Dynamics
      • 6.4.14.2. Competitive Scenario
      • 6.4.14.3. Regulatory Framework
      • 6.4.14.4. Croatia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.15. Slovenia
      • 6.4.15.1. Key Country Dynamics
      • 6.4.15.2. Competitive Scenario
      • 6.4.15.3. Regulatory Framework
      • 6.4.15.4. Slovenia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.16. Greece
      • 6.4.16.1. Key Country Dynamics
      • 6.4.16.2. Competitive Scenario
      • 6.4.16.3. Regulatory Framework
      • 6.4.16.4. Greece Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Japan Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. China Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. India Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Regulatory Framework
      • 6.5.5.4. Thailand Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. South Korea Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Australia
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Australia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Brazil Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Argentina Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. South Africa Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Saudi Arabia Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. UAE Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Kuwait Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Company Market Share/Assessment Analysis, 2024
  • 7.3. Company Profiles
    • 7.3.1. SGS Societe Generale de Surveillance SA
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Service Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Worldwide Clinical Trials
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Service Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Sofpromed
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Service Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. ClinChoice
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Service Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Evotec
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Service Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. Eurofins Scientific
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Service Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. KYMOS Group
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Service Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. ViviaBiotech S.L.
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Service Benchmarking
      • 7.3.8.4. Strategic Initiatives
    • 7.3.9. GalChimia
      • 7.3.9.1. Company Overview
      • 7.3.9.2. Financial Performance
      • 7.3.9.3. Service Benchmarking
      • 7.3.9.4. Strategic Initiatives
    • 7.3.10. TCI Laboratories
      • 7.3.10.1. Company Overview
      • 7.3.10.2. Financial Performance
      • 7.3.10.3. Service Benchmarking
      • 7.3.10.4. Strategic Initiatives
    • 7.3.11. Cotecna (NEOTRON SpA,)
      • 7.3.11.1. Company Overview
      • 7.3.11.2. Financial Performance
      • 7.3.11.3. Service Benchmarking
      • 7.3.11.4. Strategic Initiatives
    • 7.3.12. Tentamus
      • 7.3.12.1. Company Overview
      • 7.3.12.2. Financial Performance
      • 7.3.12.3. Service Benchmarking
      • 7.3.12.4. Strategic Initiatives
    • 7.3.13. Enzymlogic
      • 7.3.13.1. Company Overview
      • 7.3.13.2. Financial Performance
      • 7.3.13.3. Service Benchmarking
      • 7.3.13.4. Strategic Initiatives
    • 7.3.14. Pharmbiotest
      • 7.3.14.1. Company Overview
      • 7.3.14.2. Financial Performance
      • 7.3.14.3. Service Benchmarking
      • 7.3.14.4. Strategic Initiatives
    • 7.3.15. UNIFARM - Research Centre
      • 7.3.15.1. Company Overview
      • 7.3.15.2. Financial Performance
      • 7.3.15.3. Service Benchmarking
      • 7.3.15.4. Strategic Initiatives
    • 7.3.16. ANAPHARM EUROPE, S.L.U
      • 7.3.16.1. Company Overview
      • 7.3.16.2. Financial Performance
      • 7.3.16.3. Service Benchmarking
      • 7.3.16.4. Strategic Initiatives

List of Tables

  • Table 1 List of Tables
  • Table 2 List of Secondary Sources
  • Table 3 List of Abbreviations
  • Table 4 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 5 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 6 Global Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Region, 2018 - 2030 (USD Million)
  • Table 7 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 8 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 9 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 11 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 12 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 13 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 14 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 15 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 16 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 18 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 19 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 20 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 21 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 22 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 23 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 24 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 26 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 27 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 28 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 29 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 30 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 32 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 33 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 34 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 35 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 36 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 37 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 38 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 39 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 40 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 41 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 42 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 43 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 44 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 45 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 46 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 47 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 48 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 51 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 52 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 53 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 54 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 55 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 56 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 57 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 58 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 59 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 61 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 62 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 63 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 64 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 65 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 66 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 67 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 68 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 69 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 70 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Country, 2018 - 2030 (USD Million)
  • Table 72 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 73 Middle East & Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 74 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 75 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 78 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 79 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)
  • Table 80 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by Service, 2018 - 2030 (USD Million)
  • Table 81 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Pharmaceutical Analytical Testing Services in CRO Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Pharmaceutical Analytical Testing Services in CRO Market: Service outlook and key takeaways
  • Fig. 20 Pharmaceutical Analytical Testing Services in CRO Market: Service movement analysis
  • Fig. 21 Bioanalytical Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Non-Clinical Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Method Development & Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Extractable & Leachable Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Impurity Method Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Technical Consulting Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug Substance Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Stability Indicating Method Validation Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Accelerated Stability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Photostability Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others Service Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Pharmaceutical Analytical Testing Services in CRO Market: End Use outlook and key takeaways
  • Fig. 37 Pharmaceutical Analytical Testing Services in CRO Market: End Use movement analysis
  • Fig. 38 Pharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Biopharmaceutical Companies Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 North America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key Country Dynamics
  • Fig. 44 U.S. Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Key Country Dynamics
  • Fig. 46 Canada Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Key Country Dynamics
  • Fig. 48 Mexico Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Europe Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 UK Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Key Country Dynamics
  • Fig. 53 Germany Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Key Country Dynamics
  • Fig. 55 France Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Key Country Dynamics
  • Fig. 57 Italy Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key Country Dynamics
  • Fig. 59 Spain Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key Country Dynamics
  • Fig. 61 Denmark Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key Country Dynamics
  • Fig. 63 Sweden Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key Country Dynamics
  • Fig. 65 Norway Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key Country Dynamics
  • Fig. 67 Poland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key Country Dynamics
  • Fig. 69 Switzerland Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Austria Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 Czech Republic Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 Croatia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Slovenia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Greece Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Asia Pacific Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 81 Key Country Dynamics
  • Fig. 82 Japan Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 China Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key Country Dynamics
  • Fig. 86 India Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key Country Dynamics
  • Fig. 88 Thailand Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key Country Dynamics
  • Fig. 90 South Korea Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key Country Dynamics
  • Fig. 92 Australia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 Key Country Dynamics
  • Fig. 95 Brazil Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Key Country Dynamics
  • Fig. 97 Argentina Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 MEA Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key Country Dynamics
  • Fig. 100 South Africa Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Key Country Dynamics
  • Fig. 102 Saudi Arabia Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 103 Key Country Dynamics
  • Fig. 104 UAE Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key Country Dynamics
  • Fig. 106 Kuwait Pharmaceutical Analytical Testing Services in CRO Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key company categorization
  • Fig. 108 Service heat map analysis
  • Fig. 109 Strategic framework